Lucid Diagnostics annual r&d spending
2020
2021
2022
2023
2024
2025
Lucid Diagnostics R&D Spending Growth & History (LUCD)
Lucid Diagnostics's r&d spending was $5.7M for fiscal 2025.
View full Lucid Diagnostics company overviewLucid Diagnostics annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $5.7M | −$314,000 | −5.24% |
| 2024 | 2024-12-31 | $6.0M | −$1.3M | −17.37% |
| 2023 | 2023-12-31 | $7.3M | −$4.0M | −35.58% |
| 2022 | 2022-12-31 | $11.3M | $2.0M | +21.10% |
| 2021 | 2021-12-31 | $9.3M | $3.9M | +70.79% |
| 2020 | 2020-12-31 | $5.4M | — | — |
Lucid Diagnostics quarterly r&d spending
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.2M | −$63,000 | −5.02% |
| Q1 2026 | 2026-03-31 | $1.2M | −$222,000 | −15.55% |
| Q4 2025 | 2025-12-31 | $1.7M | $270,000 | +18.58% |
| Q3 2025 | 2025-09-30 | $1.3M | −$394,000 | −23.65% |
| Q2 2025 | 2025-06-30 | $1.3M | −$117,000 | −8.53% |
| Q1 2025 | 2025-03-31 | $1.4M | −$73,000 | −4.86% |
| Q4 2024 | 2024-12-31 | $1.5M | −$464,000 | −24.20% |
| Q3 2024 | 2024-09-30 | $1.7M | $51,000 | +3.16% |
| Q2 2024 | 2024-06-30 | $1.4M | −$455,000 | −24.90% |
| Q1 2024 | 2024-03-31 | $1.5M | −$392,000 | −20.71% |
| Q4 2023 | 2023-12-31 | $1.9M | −$315,000 | −14.11% |
| Q3 2023 | 2023-09-30 | $1.6M | −$1.1M | −40.27% |
| Q2 2023 | 2023-06-30 | $1.8M | −$1.6M | −46.89% |
| Q1 2023 | 2023-03-31 | $1.9M | −$988,000 | −34.29% |
| Q4 2022 | 2022-12-31 | $2.2M | −$1.2M | −35.88% |
| Q3 2022 | 2022-09-30 | $2.7M | $514,000 | +23.47% |
| Q2 2022 | 2022-06-30 | $3.4M | $1.6M | +83.66% |
| Q1 2022 | 2022-03-31 | $2.9M | $1.1M | +64.44% |
| Q4 2021 | 2021-12-31 | $3.5M | — | — |
| Q3 2021 | 2021-09-30 | $2.2M | $973,764 | +80.06% |
| Q2 2021 | 2021-06-30 | $1.9M | — | — |
| Q1 2021 | 2021-03-31 | $1.8M | — | — |
| Q3 2020 | 2020-09-30 | $1.2M | — | — |
Lucid Diagnostics r&d spending trends
Over the last five fiscal years, Lucid Diagnostics's r&d spending increased from $5.4M to $5.7M, a change of $235,000. The latest reported quarter, Q2 2026, shows $1.2M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Lucid Diagnostics source filings ↗